3PRZ
Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors.
Summary for 3PRZ
Entry DOI | 10.2210/pdb3prz/pdb |
Related | 3ML8 3ML9 3OAW 3PRE 3PS6 |
Descriptor | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, 4-amino-2-methyl-N-(1H-pyrazol-3-yl)quinazoline-8-carboxamide (2 entities in total) |
Functional Keywords | phosphoinositide kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 110995.38 |
Authors | Knighton, D.R.,Greasley, S.E.,Rodgers, C.M.-L. (deposition date: 2010-11-30, release date: 2011-02-09, Last modification date: 2024-02-21) |
Primary citation | Liu, K.K.,Huang, X.,Bagrodia, S.,Chen, J.H.,Greasley, S.,Cheng, H.,Sun, S.,Knighton, D.,Rodgers, C.,Rafidi, K.,Zou, A.,Xiao, J.,Yan, S. Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors. Bioorg.Med.Chem.Lett., 21:1270-1274, 2011 Cited by PubMed Abstract: Intra-molecular hydrogen bonding was introduced to the quinazoline motif to form a pseudo ring (intra-molecular H-bond scaffold, iMHBS) to mimic our previous published core structures, pyrido[2.3-D]pyrimidin-7-one and pteridinone, as PI3K/mTOR dual inhibitors. This design results in potent PI3K/mTOR dual inhibitors and the purposed intra-molecular hydrogen bonding structure is well supported by co-crystal structure in PI3Kγ enzyme. In addition, a novel synthetic route was developed for these analogs. PubMed: 21269826DOI: 10.1016/j.bmcl.2010.12.026 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.6 Å) |
Structure validation
Download full validation report